InvestorsHub Logo
Followers 5
Posts 210
Boards Moderated 0
Alias Born 10/09/2015

Re: None

Tuesday, 06/19/2018 8:38:27 AM

Tuesday, June 19, 2018 8:38:27 AM

Post# of 27587
So the question I have is, based on the latest press release and all of the speculation, press releasese by competition, and bashing of this stock, can any competitor detect and quantify ?9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and 11-nor-9-carboxy-tetrahydrocannabinol in low concentrations and low flow rates?

If so, they are competition.

If not, my opinion is they are blowing smoke.

University research projects get funded through grants. The UF analytical chemistry department has licensed their technology for commercialization to Cannabix Technologies. They get funding in return. UC Berkely is working with the lap dogs, without any real information beyond the fluff press releases (we’re the best, rah rah rah), can they detect those three molecules? The “wet chemistry” analytical process they described in a recent press release seemed to target one specific molecule. What about the other two?

A question for Huestis is, can recency of use be determined quantitatively with only the input molecule, or are the byproduct/output molecule concentrations needed as well? Same question for Draeger et al.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLOZF News